Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis

Blood

Volumn 121, Issue 18, 2013, Pages 3594-3598

  Chan, Gordon ^a   Gu, Shengqing ^a,b   Neel, Benjamin G ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MAPK1 PROTEIN, MOUSE;

ALLELE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; APLASIA; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL COUNT; CELL DIVISION; CELL PROLIFERATION; CELL SORTER; COLONY FORMING UNIT GM; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ERYTHROID CELL; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LETHALITY; LEUKOPENIA; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; ONCOGENE K RAS; PRE T LYMPHOCYTE; PRIORITY JOURNAL; STEM CELL; ADULT STEM CELL; AGE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT STEM CELLS; AGE FACTORS; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3;

MLCS; MLOWN;

EID: 84879718582     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-476200     Document Type: Article

References (20)

1. Roskoski R Jr. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012;66(2):105-143.
2. Geest CR, Coffer PJ. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol. 2009;86(2):237-250.
3. Chung E, Kondo M. Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development. Immunol Res. 2011;49(1-3):248-268.
4. Pagès G, Guérin S, Grall D, et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 1999;286(5443):1374-1377.
5. Nekrasova T, Shive C, Gao Y, et al. ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis. J Immunol. 2005;175(4):2374-2380. (Pubitemid 41113847)
6. Hatano N, Mori Y, Oh-hora M, et al. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells. 2003;8(11):847-856. (Pubitemid 37428014)
7. Saba-El-Leil MK, Vella FD, Vernay B, et al. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 2003;4(10):964-968. (Pubitemid 37407464)
8. Yao Y, Li W, Wu J, et al. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci U S A. 2003;100(22):12759-12764. (Pubitemid 37339972)
9. Fischer AM, Katayama CD, Pagès G, Pouysségur J, Hedrick SM. The role of erk1 and erk2 in multiple stages of T cell development. Immunity. 2005;23(4):431-443. (Pubitemid 41443444)
10. Johnson DE. Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis. Adv Enzyme Regul. 2008;48:98-112.
11. D'Souza WN, Chang CF, Fischer AM, Li M, Hedrick SM. The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol. 2008;181(11):7617- 7629.
12. Yasuda T, Sanjo H, Pagès G, et al. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity. 2008;28(4):499-508.
13. Benveniste P, Cantin C, Hyam D, Iscove NN. Hematopoietic stem cells engraft in mice with absolute efficiency. Nat Immunol. 2003;4(7):708-713. (Pubitemid 36874449)
14. Chan G, Cheung LS, Yang W, et al. Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood. 2011;117(16):4253-4261.
15. Rodríguez J, Crespo P. Working without kinase activity: phosphotransfer-independent functions of extracellular signal-regulated kinases. Sci Signal. 2011;4(196):re3.
16. Robinson MJ, Harkins PC, Zhang J, et al. Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5′-triphosphate. Biochemistry. 1996;35(18):5641-5646.
17. Lyubynska N, Gorman MF, Lauchle JO, et al. A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice. Sci Transl Med. 2011;3(76):76ra27.
18. Shin S, Dimitri CA, Yoon SO, Dowdle W, Blenis J. ERK2 but not ERK1 induces epithelial-tomesenchymal transformation via DEF motif-dependent signaling events. Mol Cell. 2010;38(1):114-127.
19. Staser K, Park SJ, Rhodes SD, et al. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk. J Clin Invest. 2013;123(1):329-334.
20. Zhu HH, Ji K, Alderson N, et al. Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool Blood. 2011;117(20):5350-5361.